Skip to main content
Fig. 4 | Critical Care

Fig. 4

From: Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality

Fig. 4

Hemodynamics and plasma biomarkers in patients receiving adrenaline (dark grey; A) or other vasopressor(s) (light grey; O). Boxplots show separate measurements in each time point in the upper row (biomarkers) and the mean values of time intervals in the lower row (hemodynamics): central lines median, boxes interquartile range, whiskers minimum and maximum with outliers excluded, A adrenaline, O other vasopressor, hsTnT high sensitivity troponin T, NT-proBNP N-terminal pro-B-type natriuretic peptide. *P < 0.05 for difference between adrenaline and other vasopressors. †P < 0.05 for difference between adrenaline and other vasopressors, when adjusted for resuscitation. P value for time-by-group interaction (with or without adjustment for resuscitation) shown for biomarkers, mean arterial pressure and heart rate; for CI, p value with adjustment for resuscitation shown in brackets

Back to article page

Critical Care

ISSN: 1364-8535